Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni

BACKGROUND: The control of schistosomiasis has been centered to date on a single drug, praziquantel, with shortcomings including treatment failure, reinfection, and emergence of drug resistance. Drug repurposing, combination therapy or nanotechnology were explored to improve antischistosomal treatme...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Parasit Vectors
Main Authors:	Eissa, Maha M., El-Azzouni, Mervat Z., El-Khordagui, Labiba K., Abdel Bary, Amany, El-Moslemany, Riham M., Abdel Salam, Sara A.
Format:	Artigo
Sprog:	Inglês
Udgivet:	BioMed Central 2020
Fag:	Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7493353/ https://ncbi.nlm.nih.gov/pubmed/32933556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-020-04346-1
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni

Lignende værker